Chat
Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by ELISA
2012135
Copy Utility
Ordering Recommendation
Not a first-line test for herpes simplex virus (HSV) 2 typing.
Mnemonic
HSV2 INHIB
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
Performed
Varies
Reported
3-8 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Plain red or serum separator tube (SST).
Specimen Preparation
Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Storage/Transport Temperature
Refrigerated. Also acceptable: Room temperature or frozen.
Unacceptable Conditions
Remarks
Stability
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Reference Interval
By report
Interpretive Data
No compliance statements are in use for this test.
Note
Inhibition studies are not performed on specimens with equivocal or negative results.
Hotline History
N/A
CPT Codes
86696
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2012136 | HSV-2 IgG Screening Index | 5209-2 |
| 2012137 | HSV-2 IgG Inhibition Percent | |
| 2012138 | HSV-2 IgG Inhibition Interpretation |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by ELISA
Quest Diagnostics Infectious Disease Inc.
